Pyros Pharms patent expiration

1. Vigafyde patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US12016857 PYROS PHARMS Stable liquid vigabatrin pharmaceutical composition for oral dosage
Aug, 2039

(14 years from now)




Drugs and Companies using VIGABATRIN ingredient

Market Authorisation Date: 17 June, 2024

Treatment: NA

Dosage: SOLUTION

More Information on Dosage

VIGAFYDE family patents

Family Patents